News Focus: Continuous Glucose Monitors
I am not in the news business, but if I were, type 1 diabetes would be front page, top focus, the lead story. It would be 24 hours – round the clock- coverage with no commercial interruptions. Why? As I channel my inner Howard Beale, the fictitious character in the Oscar-nominated film Network, and shout, “I’m mad as hell. …Things have got to change. But first, you’ve gotta get mad!” And, there are times when getting mad works, for my lead story today is an update on Medicare Part B coverage of therapeutic continuous glucose monitors (CGM), devices that facilitate blood-glucose management for people with type 1 diabetes.
The US Centers for Medicare and Medicaid Services has recognized continuous glucose monitors as durable medical equipment, thus paving the way toward CMS coverage of these devices for type 1 diabetes.
Visit the source link above to read the update on continuous glucose monitors in its entirety.
Dexcom, a company that develops, manufactures and distributes continuous glucose monitoring systems, applauded the decision and states:
This landmark CMS Ruling will make available the most important technology in diabetes management to the Medicare population,” said Kevin Sayer, Dexcom President and Chief Executive Officer. “We are pleased with this important step forward and we look forward to working with Medicare on implementing coverage in the coming months to ensure beneficiaries have access to this life-saving device.
What type 1 diabetes news story caught your attention this week? Feel free to share a headline in the comments section of this post.